ImuThes Ltd. is a privately owned, London (UK) based biotech company with its main activity in the field of innovative, modular, universal therapeutics for the treatment and prevention of immunological and chronic inflammatory disorders, including infections.

Acquired Companies: IC-Vec, Ltd.